J. Katner

发表

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

K. Perry, F. Bymaster, S. Hemrick-Luecke, 2002, Neuropsychopharmacology.

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neu

G. Marek, K. Perry, J. Witkin, 2011, Journal of Pharmacology and Experimental Therapeutics.

A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models.

F. Weiss, K. Perry, J. Witkin, 2016, Alcoholism, clinical and experimental research.

Typical and Atypical Antipsychotic Drugs Increase Extracellular Histamine Levels in the Rat Medial Prefrontal Cortex: Contribution of Histamine H1 Receptor Blockade

K. Perry, D. Nelson, K. Svensson, 2012, Front. Psychiatry.

The effect of lumbar sympathectomy on increased tactile sensitivity in spinal nerve ligated rats

S. Iyengar, D. Lodge, J. Katner, 2001, Neuroscience Letters.

Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge

K. Perry, K. Svensson, J. Katner, 2010, Neuropharmacology.

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat

C. Swanson, K. Perry, F. Bymaster, 2006, Neuropharmacology.

Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas

Kirk W. Johnson, K. Perry, G. Nomikos, 2008, Neuropharmacology.

Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus coeruleus of sprague-dawley rats following restraint-induced stress

S. Iyengar, J. Katner, B. Hwang, 2007, Journal of Molecular Neuroscience.

Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders

Hong Wang, Charles R. Yang, M. O'Neill, 2018, Neuropharmacology.

Role of norepinephrine in the dorsomedial hypothalamic panic response An in vivo microdialysis study

T. J. Sajdyk, A. Shekhar, A. Shekhar, 2002, Pharmacology Biochemistry and Behavior.

Monoamines in the dorsomedial hypothalamus of rats following exposure to different tests of “anxiety”

Anantha Shekhar, A. Shekhar, J. Katner, 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Ethanol and negative feedback regulation of mesolimbic dopamine release in rats

W. Mcbride, R. R. Kohl, J. Katner, 1998, Psychopharmacology.

Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test

A. Shekhar, J. Katner, Anantha Shekhar, 1995, Pharmacology Biochemistry and Behavior.

Synthesis and Preclinical Characterization of LY3154885, a Human Dopamine D1 Receptor Positive Allosteric Modulator with an Improved Nonclinical Drug-Drug Interaction Risk Profile.

M. Mohutsky, M. Posada, E. Hembre, 2022, Journal of medicinal chemistry.

Fear-potentiated startle elevates catecholamine levels in the dorsomedial hypothalamus of rats

A. Shekhar, J. Katner, J. Simon, 1994, Pharmacology Biochemistry and Behavior.

Modulation of neurotransmitter release in orexin/hypocretin‐2 receptor knockout mice: A microdialysis study

K. Perry, G. Nomikos, L. Nisenbaum, 2012, Journal of neuroscience research.

In Vivo Characterization of Changes in Glycine Levels Induced by GlyT1 Inhibitors

F. Bymaster, L. Phebus, H. Shannon, 2003, Annals of the New York Academy of Sciences.